Home

The Best-in-Class Fully Human Antibody Mouse.

in situ V(D)J substitution Fully Human Variable Domain Murine Constant Region

RenMab™

Best-in-class fully human antibody platform
Available for licensing now

Fully human heavy chain and kappa light chain V(D)J loci substitution

RenLite™

Bispecific or Multispecific antibody discovery platform
Available for licensing now

Fully human heavy chain repertoire combined with a common light chain substitution

RenNano™

Heavy chain only antibody (HcAb) or Nanobody platform
Coming soon

Fully human heavy chain VDJ loci substitution with heavy chain CH1 knocked out

RenMice™ HiTS Platform

The RenMice™ HiTS (Hyperimmune Target Specific) Platform consists of a library of RenMice™ each with a specific target gene knocked out. These mice are designed to elicit robust immune responses against homologous proteins and generate antibodies that bind to broader epitopes.

Learn More
Search

BIOCYTOGEN & RENMAB COMMERCIAL BENEFITS

Licensing Options

License directly with Biocytogen
Option to use through other CROs or in-house

Co-development Opportunities

Exclusive partnership opportunities using our RenMiceTM HiTS Platform

Flexibility

Flexible terms tailored to accommodate different antibody programs